Clinical Trial Update: Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating efficacy and safety of Kui-Yuan Chewable Tablets in hyperuricemia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• Kui-Yuan Chewable Tablets

Snippet

Sponsor: Quan Jiang | Conditions: Hyperuricemia | Phase 4 | Status: UNKNOWN